東方盛虹(000301.SZ):控股股東及其關聯企業部分員工籌劃增持公司股份 籌資總額不超14.68億元
格隆匯3月11日丨東方盛虹(000301.SZ)公佈,公司於2022年3月11日接到公司控股股東江蘇盛虹科技股份有限公司(簡稱“盛虹科技”)的通知,盛虹科技及其關聯企業(除上市公司及上市公司控股子公司外)的部分員工(簡稱“增持人員”)擬通過二級市場購買方式增持上市公司股份(簡稱“本次增持”)。
本次增持擬通過設立專項金融產品、證券公司融資融券、資管/信託產品等法律法規允許的方式實施,融資資金與自籌資金的比例不超過1:1,籌集資金總額不超過14.68億元。具體認購規模將根據參與者的認購情況而定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.